Correlation Between Morgan Stanley and EXPRES2ION BIOTECH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and EXPRES2ION BIOTECH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and EXPRES2ION BIOTECH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and EXPRES2ION BIOTECH HLDG, you can compare the effects of market volatilities on Morgan Stanley and EXPRES2ION BIOTECH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of EXPRES2ION BIOTECH. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and EXPRES2ION BIOTECH.

Diversification Opportunities for Morgan Stanley and EXPRES2ION BIOTECH

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Morgan and EXPRES2ION is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and EXPRES2ION BIOTECH HLDG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EXPRES2ION BIOTECH HLDG and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with EXPRES2ION BIOTECH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EXPRES2ION BIOTECH HLDG has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and EXPRES2ION BIOTECH go up and down completely randomly.

Pair Corralation between Morgan Stanley and EXPRES2ION BIOTECH

Given the investment horizon of 90 days Morgan Stanley is expected to generate 1.53 times less return on investment than EXPRES2ION BIOTECH. But when comparing it to its historical volatility, Morgan Stanley Direct is 12.79 times less risky than EXPRES2ION BIOTECH. It trades about 0.11 of its potential returns per unit of risk. EXPRES2ION BIOTECH HLDG is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  260.00  in EXPRES2ION BIOTECH HLDG on September 22, 2024 and sell it today you would lose (77.00) from holding EXPRES2ION BIOTECH HLDG or give up 29.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

Morgan Stanley Direct  vs.  EXPRES2ION BIOTECH HLDG

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
EXPRES2ION BIOTECH HLDG 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in EXPRES2ION BIOTECH HLDG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, EXPRES2ION BIOTECH may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Morgan Stanley and EXPRES2ION BIOTECH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and EXPRES2ION BIOTECH

The main advantage of trading using opposite Morgan Stanley and EXPRES2ION BIOTECH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, EXPRES2ION BIOTECH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXPRES2ION BIOTECH will offset losses from the drop in EXPRES2ION BIOTECH's long position.
The idea behind Morgan Stanley Direct and EXPRES2ION BIOTECH HLDG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities